Cargando…
Assessing the Highest Level of Evidence from Randomized Controlled Trials in Omega-3 Research
Over the years, there has been heightened interest in the health benefits of n-3 polyunsaturated fatty acids (PUFA) in reducing chronic diseases such as, cardiovascular disease (CVD), cancer, type 2 diabetes, and acute macular degeneration (AMD). Due to inconsistent findings in the evidence, a revie...
Autores principales: | Sahye-Pudaruth, Sandhya, Ma, David W. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959429/ https://www.ncbi.nlm.nih.gov/pubmed/36839358 http://dx.doi.org/10.3390/nu15041001 |
Ejemplares similares
-
Selenium, antioxidants, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials
por: Jenkins, David J A, et al.
Publicado: (2020) -
Randomized Controlled Trials in ICU in the Four Highest-Impact General Medicine Journals
por: Kampman, Jasper M., et al.
Publicado: (2023) -
Reporting quality of randomized controlled trial abstracts in the seven highest-ranking anesthesiology journals
por: Janackovic, Katja, et al.
Publicado: (2018) -
Peruvian research: striving for the highest standards
por: Arévalo, Jorge, et al.
Publicado: (2021) -
Clinical Assessment of Efficacy of Omega 3 in Oral Submucous Fibrosis Patients - A Randomized Controlled Trial
por: aizada, Milanjeet Kaur, et al.
Publicado: (2022)